A tumor active targeting nano drug delivery system that can reverse tumor drug resistance

A nano-drug delivery system and active targeting technology, which can be used in anti-tumor drugs, drug combinations, anti-infective drugs, etc., and can solve problems such as poor hydrophilicity, low drug loading, and capture

CN104398493BInactive Publication Date: 2017-06-30FOURTH MILITARY MEDICAL UNIVERSITY
2 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Publication Date
2017-06-30
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention provides a tumor active-targeting nano drug delivery system capable of reversing drug-resistance. The drug delivery system is polylactic-co-glycolic acid (PLGA) nanoparticles mixed with lipid, and the nanoparticle core is PLGA. Drug-loaded nanoparticles are prepared as follows: inserting AA-polyethylene glycol-cholesterol linkers and triphenylphosphine-cholesterol linkers in the surface of PLGA; encapsulating DOX into the PLGA nanoparticles mixed with lipid to obtain the drug-loaded nanoparticles. The drug delivery system has the acid sensitivity, which enables the drug delivery system to proactively recognize tumor cells and position and release DOX into the mitochondria and cell nuclei of tumor cells, thereby enhancing the anti-tumor activity, reversing the drug-resistance of the tumor and providing a new strategy for improving the efficacy of DOX.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The present invention relates to a prescription composition and application scheme of a tumor active targeting nano drug delivery system capable of reversing drug resistance of tumors. The drug delivery system is a novel lipid mixed polylactic acid-glycolic acid copolymer ( PLGA) nanoparticles. Background technique

[0002] Tumor is a kind of disease that seriously threatens human health. Doxorubicin (DOX) is the first-line drug for tumor chemotherapy, with definite curative effect and low price, but its clinical application is limited by its toxic side effects on normal tissues and easy drug resistance. Therefore, taking doxorubicin as the research object, construct a new drug delivery system with both tumor targeting and acid-sensitivity properties, increase the content of doxorubicin in tumor tissues, reduce its distribution in normal tissues, and reverse drug resistance, and obtain A novel tumor-targeted drug delivery system with high efficiency ...

Examples

Embodiment Construction

[0021] Preparation and antitumor activity of doxorubicin tumor-targeted drug delivery system

[0022] 1 Objective: To evaluate the antitumor activity of DOX-loaded lipid-mixed PLGA nanoparticles.

[0023] 2 Research methods:

[0024] 2.1 Determination of encapsulation efficiency and drug loading

[0025] The nanoparticles were dissolved in DMSO to destroy the nanoparticle structure, and the encapsulation efficiency and drug loading were detected by HPLC-MS / MS.

[0026] Drug loading = (the amount of drug wrapped in the drug delivery system / weight of the drug delivery system) × 100%

[0027] Encapsulation efficiency = (actual drug loading / dosage) × 100%

[0028] 2.2 Evaluation of acid sensitivity characteristics

[0029] The lipid-mixed PLGA nanoparticles were weighed, and the Zeta potential of the lipid-mixed PLGA nanoparticles in different pH (pH 5.0, pH 6.5 and pH 7.4) media was analyzed by laser particle size analyzer.

[0030] 2.3 Cytotoxicity evaluation

[0031] Huma...